Intrinsic Value of S&P & Nasdaq Contact Us

GSK plc GLAXF OTC

Other OTC • Healthcare • Drug Manufacturers - General • GB • USD

SharesGrow Score
72/100
4/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

GSK plc (GLAXF) reported total assets of $61.11B and total liabilities of $45.09B for quarter ending 2025-12-31, resulting in total equity of $15.95B.

The company held $3.41B in cash and short-term investments. Total debt stood at $17.72B, with net debt of $14.32B. The Debt-to-Equity (D/E) ratio was 1.11 (moderate).

Current ratio is 0.82, which may signal tight short-term liquidity. Interest coverage is 5.1x (adequate).

Criteria supported by this page:

  • HEALTH (50/100, Partial) — some metrics are adequate but not all reach ideal thresholds
  • MOAT (90/100) — Total assets $61.11B and equity $15.95B support the company's competitive scale
  • VALUE (75/100) — Debt-to-Equity 1.11 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 70/100 with 4/7 criteria passed.

SharesGrow 7-Criteria Score
72/100
SG Score
View full scorecard →
VALUE
75/100
Price-to-Earnings & upside
→ Valuation
FUTURE
N/A
No coverage
PAST
100/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
90/100
Proven by this page
~
GROWTH
45/100
→ Income
INCOME
70/100
→ Income
GSK plc Balance Sheet History
Metric Q4 FY2025 Q3 FY2025 Q2 FY2025 Q1 FY2025
Total Assets $61.11B$61.34B$59.26B$60.71B
Total Liabilities $45.09B$45.59B$44.9B$47.05B
Total Debt $17.72B$17.75B$0.00$0.00
Cash & Investments $3.41B$3.31B$3.62B$4.49B
Total Stockholders Equity $16.37B$16.15B$14.79B$14.16B
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message